Catalyst Capital Advisors LLC Trims Holdings in CME Group Inc. $CME

24 Oct 2025, 10:36 by Teresa Graham · The Cerbat Gem

Catalyst Capital Advisors LLC decreased its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 14.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,135 shares of the financial services provider’s stock after selling 527 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in CME Group were worth $864,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. OMNI 360 Wealth Inc. acquired a new position in CME Group in the 1st quarter valued at $367,000. Fulcrum Equity Management acquired a new position in CME Group in the 1st quarter valued at $258,000. AIA Group Ltd increased its stake in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after buying an additional 2,510 shares during the period. Insight Inv LLC acquired a new position in CME Group in the 1st quarter valued at $2,712,000. Finally, Summit Trail Advisors LLC increased its stake in CME Group by 28.8% in the 1st quarter. Summit Trail Advisors LLC now owns 5,323 shares of the financial services provider’s stock valued at $1,412,000 after buying an additional 1,189 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CME. Jefferies Financial Group dropped their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. UBS Group dropped their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Deutsche Bank Aktiengesellschaft raised shares of CME Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $266.00 to $300.00 in a research note on Thursday. Finally, Piper Sandler upped their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $284.53.

Check Out Our Latest Report on CME

CME Group Stock Performance

NASDAQ:CME opened at $268.90 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The stock has a market cap of $96.91 billion, a PE ratio of 26.06, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41. The firm’s fifty day simple moving average is $266.56 and its 200-day simple moving average is $271.57.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.68 EPS. Analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is presently 48.40%.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of the stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director owned 258,459 shares in the company, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last quarter. Insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)